Date of download: 6/18/2016 From: Treatment of Anemia in Patients With Heart Disease: A Systematic Review Ann Intern Med. 2013;159(11): doi: / Analytic framework. Figure Legend: Copyright © American College of Physicians. All rights reserved.American College of Physicians
Date of download: 6/18/2016 From: Treatment of Anemia in Patients With Heart Disease: A Systematic Review Ann Intern Med. 2013;159(11): doi: / Summary of evidence search and selection. CHD = coronary heart disease; CHF = congestive heart failure; ESA = erythropoiesis-stimulating agent; RCT = randomized, controlled trial. Figure Legend: Copyright © American College of Physicians. All rights reserved.American College of Physicians
Date of download: 6/18/2016 From: Treatment of Anemia in Patients With Heart Disease: A Systematic Review Ann Intern Med. 2013;159(11): doi: / d mortality among patients with congestive heart failure or coronary heart disease in liberal versus restrictive blood transfusion protocols. RR = risk ratio. Figure Legend: Copyright © American College of Physicians. All rights reserved.American College of Physicians
Date of download: 6/18/2016 From: Treatment of Anemia in Patients With Heart Disease: A Systematic Review Ann Intern Med. 2013;159(11): doi: / Cardiovascular events among patients with congestive heart failure or coronary heart disease in liberal versus restrictive blood transfusion protocols. MI = myocardial infarction; RR = risk ratio. Figure Legend: Copyright © American College of Physicians. All rights reserved.American College of Physicians
Date of download: 6/18/2016 From: Treatment of Anemia in Patients With Heart Disease: A Systematic Review Ann Intern Med. 2013;159(11): doi: / All-cause mortality among patients with congestive heart failure or coronary heart disease treated with erythropoiesis-stimulating agents versus control treatment. RR = risk ratio. * High or unclear risk of bias. Figure Legend: Copyright © American College of Physicians. All rights reserved.American College of Physicians
Date of download: 6/18/2016 From: Treatment of Anemia in Patients With Heart Disease: A Systematic Review Ann Intern Med. 2013;159(11): doi: / Change in NYHA score among patients with congestive heart failure treated with erythropoiesis-stimulating agents compared with control patients. NYHA = New York Heart Association. * High or unclear risk of bias. Figure Legend: Copyright © American College of Physicians. All rights reserved.American College of Physicians
Date of download: 6/18/2016 From: Treatment of Anemia in Patients With Heart Disease: A Systematic Review Ann Intern Med. 2013;159(11): doi: / Change in NYHA score among patients with congestive heart failure treated with erythropoiesis-stimulating agents versus control patients in studies with low risk of bias. NYHA = New York Heart Association. Figure Legend: Copyright © American College of Physicians. All rights reserved.American College of Physicians
Date of download: 6/18/2016 From: Treatment of Anemia in Patients With Heart Disease: A Systematic Review Ann Intern Med. 2013;159(11): doi: / Change in 6-minute walk distance among patients with congestive heart failure treated with erythropoiesis-stimulating agents compared with control patients. * High or unclear risk of bias. Figure Legend: Copyright © American College of Physicians. All rights reserved.American College of Physicians
Date of download: 6/18/2016 From: Treatment of Anemia in Patients With Heart Disease: A Systematic Review Ann Intern Med. 2013;159(11): doi: / Risk for hospitalization among patients with congestive heart failure or coronary heart disease treated with erythropoiesis-stimulating agents versus control patients in studies with low risk of bias. NR = not reported; RR = risk ratio. Figure Legend: Copyright © American College of Physicians. All rights reserved.American College of Physicians
Date of download: 6/18/2016 From: Treatment of Anemia in Patients With Heart Disease: A Systematic Review Ann Intern Med. 2013;159(11): doi: / Cardiovascular events among patients with congestive heart failure or coronary heart disease treated with erythropoiesis-stimulating agents compared with control patients. NR = not reported; RR = risk ratio. * High or unclear risk of bias. Figure Legend: Copyright © American College of Physicians. All rights reserved.American College of Physicians
Date of download: 6/18/2016 From: Treatment of Anemia in Patients With Heart Disease: A Systematic Review Ann Intern Med. 2013;159(11): doi: / Cerebrovascular events among patients with congestive heart failure or coronary heart disease treated with erythropoiesis-stimulating agents compared with control patients. RR = risk ratio. * Unclear risk of bias. Figure Legend: Copyright © American College of Physicians. All rights reserved.American College of Physicians
Date of download: 6/18/2016 From: Treatment of Anemia in Patients With Heart Disease: A Systematic Review Ann Intern Med. 2013;159(11): doi: / Hypertension events among patients with congestive heart failure or coronary heart disease treated with erythropoiesis-stimulating agents compared with control patients. RR = risk ratio. * Unclear risk of bias. Figure Legend: Copyright © American College of Physicians. All rights reserved.American College of Physicians
Date of download: 6/18/2016 From: Treatment of Anemia in Patients With Heart Disease: A Systematic Review Ann Intern Med. 2013;159(11): doi: / Venous thromboembolic events among patients with congestive heart failure or coronary heart disease treated with erythropoiesis-stimulating agents compared with control patients. RR = risk ratio. Figure Legend: Copyright © American College of Physicians. All rights reserved.American College of Physicians